Lance Mynderse, M.D.
NPI 1700865938 · Urology Physician · Rochester, MN
Enrolled with Medicare as Practitioner - Urology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Lance Mynderse, M.D. is a Urology Physician provider in Rochester, MN (NPI 1700865938).
Provider details
- NPI number
- 1700865938
- Entity type
- Individual
- Primary specialty
- Urology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 31792 (MN)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
20 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
581 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Diagnostic Exam of Bladder and Urethra Using an Endoscope52000 | 99 | $244 |
| Biopsy of Prostate Gland55700 | 62 | $120 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 57 | $130 |
| Ultrasound Scan of Pelvic Region Through Rectum76872 | 54 | $33 |
| Imaging of Urinary Tract Following Injection of a Contrast Agent74420 | 43 | $24 |
| Biopsy of Prostate Gland55700 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 4 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Finasteride | 27 | — |
| Tamsulosin Hcl | 15 | — |
| Cefdinir | 12 | 12 |
| Mirabegronbrand: Myrbetriq | 11 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do notinclude cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-01-16
- Last updated
- 2026-04-10
- Certified
- 2026-04-10
Frequently asked questions
- What is Lance Mynderse's NPI number?
- Lance Mynderse's National Provider Identifier (NPI) is 1700865938, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Lance Mynderse's specialty?
- Lance Mynderse is listed in the NPPES registry with a primary specialty of Urology Physician (Allopathic & Osteopathic Physicians).
- Where is Lance Mynderse located?
- Lance Mynderse's practice location on file with NPPES is 200 1st St Sw, Rochester, MN 55905-0001.
- What is Lance Mynderse's phone number?
- The practice phone number listed in the NPPES registry for Lance Mynderse is (507) 284-2511.
- Does Lance Mynderse accept Medicare?
- Lance Mynderse is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Lance Mynderse's NPI active?
- Yes — Lance Mynderse's NPI (1700865938) is active in the NPPES registry as of the last update on 2026-04-10.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.